S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

from Opthamology @Point of Care Podcasts

In this episode, our faculty take a deeper dive into their discussion of treatments of neovascular AMD, including anti-VEGF agents and some of the newer agents, including a bispecific antibody that inhibits both VEGF and Ang2. Visit www.morningcommutepodcast.com/AMD2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

Episode metadata supplied by the publisher feed · Published Jan 12, 2024

Embed this episode

Attribution link and audio player

Ready to play

S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

0:00 22:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Opthamology @Point of Care Podcasts?

This episode is 22 minutes long.

When was this Opthamology @Point of Care Podcasts episode published?

This episode was published on January 12, 2024.

Can I download this Opthamology @Point of Care Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!